September 11th, 2023 – Paris, France – Owkin and Tribun Health announce a strategic partnership to advance the development and global deployment of Artificial Intelligence (AI) Diagnostic and Research solutions for pathology...

Paris, France – September 05, 2023: Tribun Health, a leading innovator in the field of digital pathology, is delighted to announce the completion of its Series B financing round, securing an investment of €15 million. This financing...

Owkin: World's first AI diagnostic for MSI prescreening from routine H&E slides for colorectal cancer aims to help pathologists and oncologists facilitate better access to approved immunotherapy treatments for their patients. PARIS, June...

Today, Nature Medicine published groundbreaking Owkin research demonstrating the first-ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data. At Owkin, we are on a journey to...

In recent years, artificial intelligence developers have changed the face of medicine with algorithms capable of detecting the earliest signs of cancer. Owkin, meanwhile, is taking a slightly different approach with its own cancer-spotting...

Findings presented at European Society of Medical Oncology 21-09-2021, New York, NY and Paris, France— The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health Challenge organized by the Ile-de-France...